{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:01:29Z","timestamp":1793883689259,"version":"4.7.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR46398\/AAQ\/1\/850\/2022"],"award-info":[{"award-number":["BT\/PR46398\/AAQ\/1\/850\/2022"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.virol.2024.110239","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T10:06:19Z","timestamp":1726221979000},"page":"110239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Evolution of drug resistance against antiviral agents that target cellular factors"],"prefix":"10.1016","volume":"600","author":[{"given":"Naveen","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra Kumar","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Barua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110239_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02030117","article-title":"Selection for bacteriophage latent period length by bacterial density: a theoretical examination","volume":"18","author":"Abedon","year":"1989","journal-title":"Microb. Ecol."},{"key":"10.1016\/j.virol.2024.110239_bib2","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1128\/AEM.69.12.7499-7506.2003","article-title":"Experimental examination of bacteriophage latent-period evolution as a response to bacterial availability","volume":"69","author":"Abedon","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.virol.2024.110239_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cei.13295","article-title":"Emerging viruses and current strategies for vaccine intervention","volume":"196","author":"Afrough","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.virol.2024.110239_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.virol.2024.110239_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coi.2018.10.007","article-title":"Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control","volume":"56","author":"Andreakos","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virol.2024.110239_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/acsinfecdis.5b00122","article-title":"Mechanism of poliovirus resistance to host phosphatidylinositol-4 kinase III beta inhibitor","volume":"2","author":"Arita","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virol.2024.110239_bib7","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.3390\/v7082840","article-title":"Regulation of the host antiviral state by intercellular communications","volume":"7","author":"Assil","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110239_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-3542(98)00003-5","article-title":"Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease","volume":"38","author":"Awan","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32693-8","article-title":"Reconstructing the evolutionary history of pandemic foot-and-mouth disease viruses: the impact of recombination within the emerging O\/ME-SA\/Ind-2001 lineage","volume":"8","author":"Bachanek-Bankowska","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2024.110239_bib10","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.3748\/wjg.v20.i33.11641","article-title":"Management of antiviral drug resistance in chronic hepatitis B","volume":"20","author":"Bang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virol.2024.110239_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2017.03.009","article-title":"Direct-acting antivirals and host-targeting strategies to combat enterovirus infections","volume":"24","author":"Bauer","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2024.110239_bib13","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3389\/fmicb.2017.01557","article-title":"Protein-protein interactions in virus-host systems","volume":"8","author":"Brito","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2024.110239_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2217","article-title":"Role of p38 mitogen-activated protein kinase signalling in virus replication and potential for developing broad spectrum antiviral drugs","volume":"31","author":"Chander","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msac177","article-title":"Resistance evolution against host-directed antiviral agents: buffalopox virus switches to use p38-upsilon under long-term selective pressure of an inhibitor targeting p38-alpha","volume":"39","author":"Chander","year":"2022","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.virol.2024.110239_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2148-12-37","article-title":"A common, non-optimal phenotypic endpoint in experimental adaptations of bacteriophage lysis time","volume":"12","author":"Chantranupong","year":"2012","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.virol.2024.110239_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1099\/vir.0.018531-0","article-title":"Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes","volume":"91","author":"Chatterji","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib19","doi-asserted-by":"crossref","DOI":"10.15190\/d.2022.10","article-title":"Remdesivir: the first FDA-approved anti-COVID-19 treatment for young children","volume":"10","author":"Chera","year":"2022","journal-title":"Discoveries"},{"key":"10.1016\/j.virol.2024.110239_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010722","article-title":"TNFalpha-induced metabolic reprogramming drives an intrinsic anti-viral state","volume":"18","author":"Ciesla","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2024.110239_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/AAC.00939-08","article-title":"Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors","volume":"53","author":"Coelmont","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2024.110239_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1749-6632.1990.tb17843.x","article-title":"Antiviral drug resistance","volume":"616","author":"Coen","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.virol.2024.110239_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.coviro.2011.10.024","article-title":"Antiviral drugs and antiviral drug resistance","volume":"1","author":"Coen","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/mdh027","article-title":"Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma","volume":"15","author":"Comoli","year":"2004","journal-title":"Ann. Oncol. : Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.virol.2024.110239_bib25","first-page":"243","article-title":"Immunoregulatory defects associated with infection with the AIDS virus, HTLV-III","volume":"4","author":"Crapper","year":"1987","journal-title":"Concepts Immunopathol."},{"key":"10.1016\/j.virol.2024.110239_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/emboj\/16.2.295","article-title":"Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK\/p38)","volume":"16","author":"Cuenda","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2024.110239_bib27","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.virol.2024.110239_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13091","article-title":"Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplant","volume":"21","author":"Cunningham","year":"2019","journal-title":"Transpl. Infect. Dis. : Off. J Transplant. Soc."},{"key":"10.1016\/j.virol.2024.110239_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coviro.2013.03.012","article-title":"HIV-1 reverse transcriptase and antiviral drug resistance. Part 1","volume":"3","author":"Das","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(01)00167-6","article-title":"Antiviral drugs: current state of the art","volume":"22","author":"De Clercq","year":"2001","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Clin. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2024.110239_bib32","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/MPH.0b013e3181bf5e2d","article-title":"Adoptive transfer of cytomegalovirus\/Epstein-Barr virus-specific immune effector cells for therapeutic and preventive\/preemptive treatment of pediatric allogeneic cell transplant recipients","volume":"32","author":"Dong","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.virol.2024.110239_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cell.2006.01.034","article-title":"Anti-immunology: evasion of the host immune system by bacterial and viral pathogens","volume":"124","author":"Finlay","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.virol.2024.110239_bib34","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2010.04.020","article-title":"The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection","volume":"53","author":"Foerster","year":"2010","journal-title":"J. Hepatol."},{"issue":"953\u2013964","key":"10.1016\/j.virol.2024.110239_bib35","first-page":"964 e951","article-title":"Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes","volume":"139","author":"Fofana","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2024.110239_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064221","article-title":"A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission","volume":"8","author":"Fofana","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110239_bib37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13469","article-title":"Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations","volume":"513","author":"Fridman","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virol.2024.110239_bib38","article-title":"Correction: accelerating influenza research: vaccines, antivirals, immunomodulators and monoclonal antibodies. The manufacture of a new wild-type H3N2 virus for the human viral challenge model","volume":"11","author":"Fullen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110239_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chom.2017.07.012","article-title":"Ten strategies of interferon evasion by viruses","volume":"22","author":"Garcia-Sastre","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2024.110239_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/v10020055","article-title":"CRISPR-Cas9 genetic analysis of virus-host interactions","volume":"10","author":"Gebre","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110239_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coviro.2014.07.005","article-title":"The evolution of life history trade-offs in viruses","volume":"8","author":"Goldhill","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crvi.2004.04.005","article-title":"Pathogen recognition or homeostasis? APC receptor functions in innate immunity","volume":"327","author":"Gordon","year":"2004","journal-title":"Comptes Rendus Biol."},{"key":"10.1016\/j.virol.2024.110239_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2007.10.003","article-title":"Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock","volume":"78","author":"Goris","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.rvsc.2013.11.010","article-title":"Immunoregulatory effects of Taishan Pinus massoniana pollen polysaccharide on chicks co-infected with avian leukosis virus and Bordetella avium early in ovo","volume":"96","author":"Guo","year":"2014","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.virol.2024.110239_bib45","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/bioinformatics\/btu763","article-title":"Molecular principles of human virus protein-protein interactions","volume":"31","author":"Halehalli","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2024.110239_bib46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/JVI.01374-07","article-title":"Amiloride derivatives inhibit coxsackievirus B3 RNA replication","volume":"82","author":"Harrison","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib47","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1558-5646.2007.00132.x","article-title":"Testing optimality with experimental evolution: lysis time in a bacteriophage","volume":"61","author":"Heineman","year":"2007","journal-title":"Evol.Int. J. Org. Evol."},{"key":"10.1016\/j.virol.2024.110239_bib48","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1128\/JVI.75.17.8187-8194.2001","article-title":"Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis","volume":"75","author":"Henke","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib49","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","volume":"108","author":"Hoffmann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2024.110239_bib50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.27815","article-title":"Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins","volume":"62","author":"Hopcraft","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2024.110239_bib51","first-page":"911","article-title":"[Viruses and antiviral drug resistance]","volume":"118","author":"Hovi","year":"2002","journal-title":"Duodecim; laaketieteellinen aikakauskirja"},{"key":"10.1016\/j.virol.2024.110239_bib52","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4049\/jimmunol.179.2.1122","article-title":"Protection from lethal infection by adoptive transfer of CD8 T cells genetically engineered to express virus-specific innate immune receptor","volume":"179","author":"Iizuka","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2024.110239_bib53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/cid\/ciz949","article-title":"Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates compared with rates during the interferon era","volume":"71","author":"Ingiliz","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110239_bib54","article-title":"Antiviral drug resistance as an adaptive process","volume":"2","author":"Irwin","year":"2016","journal-title":"Virus evolu."},{"key":"10.1016\/j.virol.2024.110239_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mol.107.035055","article-title":"CCR5 small-molecule antagonists and monoclonal antibodies exert potent synergistic antiviral effects by cobinding to the receptor","volume":"72","author":"Ji","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.virol.2024.110239_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2427(98)00086-5","article-title":"Type 1 and type 2 cytokines in antiviral defense","volume":"63","author":"Karupiah","year":"1998","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.virol.2024.110239_bib57","series-title":"Studies on the Antiviral Activity of Apigenin against Buffalopox Virus","author":"Khandelwal","year":"2022"},{"key":"10.1016\/j.virol.2024.110239_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104870","article-title":"Antiviral activity of Apigenin against buffalopox: novel mechanistic insights and drug-resistance considerations","volume":"181","author":"Khandelwal","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.antiviral.2017.06.006","article-title":"Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants","volume":"144","author":"Khandelwal","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2014.06.011","article-title":"Silver nanoparticles impair Peste des petits ruminants virus replication","volume":"190","author":"Khandelwal","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2024.110239_bib61","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9965","article-title":"Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs","volume":"8","author":"Kouznetsova","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.virol.2024.110239_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01316730","article-title":"Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus","volume":"91","author":"Kraaijeveld","year":"1986","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020069","article-title":"Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases","volume":"6","author":"Krumm","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110239_bib64","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1074\/jbc.M414221200","article-title":"BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo","volume":"280","author":"Kuma","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2024.110239_bib65","first-page":"1","article-title":"Investigating the mechanisms underlying acquisition of antiviral drug resistance against host-targeting agent","author":"Kumar","year":"2022","journal-title":"Rep. sub. Sci. Eng. Res. Board"},{"key":"10.1016\/j.virol.2024.110239_bib66","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2190647","article-title":"Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India","volume":"14","author":"Kumar","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.virol.2024.110239_bib67","first-page":"389","article-title":"Systems perspective of morbillivirus replication","volume":"26","author":"Kumar","year":"2016","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.virol.2024.110239_bib68","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jviromet.2013.03.002","article-title":"Isolation, identification and characterization of a Peste des Petits Ruminants virus from an outbreak in Nanakpur, India","volume":"189","author":"Kumar","year":"2013","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.virol.2024.110239_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fmicb.2019.00209","article-title":"Inhibitor of sarco\/endoplasmic reticulum calcium-ATPase impairs multiple steps of paramyxovirus replication","volume":"10","author":"Kumar","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2024.110239_bib70","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/JVI.01969-10","article-title":"Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication","volume":"85","author":"Kumar","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib71","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1128\/AAC.00725-11","article-title":"Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses","volume":"55","author":"Kumar","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2024.110239_bib72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1863-2378.2007.01075.x","article-title":"Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India)","volume":"54","author":"Kumar","year":"2007","journal-title":"Zoonoses Publ. health"},{"key":"10.1016\/j.virol.2024.110239_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00111-17","article-title":"Virological and immunological outcomes of coinfections","volume":"31","author":"Kumar","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2024.110239_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00168-19","article-title":"Host-directed antiviral therapy","volume":"33","author":"Kumar","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2024.110239_bib75","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1080\/21505594.2022.2141971","article-title":"A serious skin virus epidemic sweeping through the Indian subcontinent is a threat to the livelihood of farmers","volume":"13","author":"Kumar","year":"2022","journal-title":"Virulence"},{"key":"10.1016\/j.virol.2024.110239_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105056","article-title":"Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E","volume":"189","author":"Kumar","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199105","article-title":"Role of ROCK signaling in virus replication","volume":"329","author":"Kumar","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2024.110239_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21610-9","article-title":"ROCK1\/MLC2 inhibition induces decay of viral mRNA in BPXV infected cells","volume":"12","author":"Kumar","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2024.110239_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105232","article-title":"S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants","volume":"197","author":"Kumar","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib80","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2018.10.022","article-title":"MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesis","volume":"160","author":"Kumar","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virusres.2018.05.028","article-title":"Role of MAPK\/MNK1 signaling in virus replication","volume":"253","author":"Kumar","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2024.110239_bib82","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.1997.6849","article-title":"Novel homologues of CSBP\/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles","volume":"235","author":"Kumar","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2024.110239_bib83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2012.02.018","article-title":"Human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice","volume":"57","author":"Lacek","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2024.110239_bib84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12931-018-0784-1","article-title":"The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics","volume":"19","author":"Lambkin-Williams","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib85","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MOP.0000000000001176","article-title":"Host-directed immunotherapy to fight infectious diseases","volume":"34","author":"Langelier","year":"2022","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.virol.2024.110239_bib86","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1159\/000375161","article-title":"Antiviral and immunoregulatory effects of indoleamine-2,3-dioxygenase in hepatitis C virus infection","volume":"7","author":"Lepiller","year":"2015","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.virol.2024.110239_bib87","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.aaj2191","article-title":"Antibiotic tolerance facilitates the evolution of resistance","volume":"355","author":"Levin-Reisman","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110239_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-8976-8_1","article-title":"Overview of direct-acting antiviral drugs and drug resistance of hepatitis C virus","volume":"1911","author":"Li","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2024.110239_bib89","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/j.spid.2005.07.002","article-title":"Avian influenza virus H5N1: a review of its history and information regarding its potential to cause the next pandemic","volume":"16","author":"Ligon","year":"2005","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110239_bib90","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1128\/JVI.79.12.7363-7370.2005","article-title":"Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion","volume":"79","author":"Liu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib91","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cld.2010.05.004","article-title":"Drug resistance in antiviral therapy","volume":"14","author":"Locarnini","year":"2010","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.virol.2024.110239_bib92","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4149\/av_2013_02_171","article-title":"Interferons lambda, new cytokines with antiviral activity","volume":"57","author":"Lopusna","year":"2013","journal-title":"Acta Virol."},{"key":"10.1016\/j.virol.2024.110239_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coviro.2018.03.007","article-title":"CRISPR genetic screens to discover host-virus interactions","volume":"29","author":"McDougall","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib94","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.22547","article-title":"Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo","volume":"48","author":"Meuleman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2024.110239_bib95","first-page":"327","article-title":"p38-MAPK is prerequisite for the synthesis of SARS-CoV-2 protein","volume":"35","author":"Mittal","year":"2024","journal-title":"Virus Dis."},{"key":"10.1016\/j.virol.2024.110239_bib96","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/iai.33.3.743-749.1981","article-title":"Recovery of mice from herpes simplex virus type 2 hepatitis: adoptive transfer of recovery with immune spleen cells","volume":"33","author":"Mogensen","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2024.110239_bib97","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1386207323999200728115857","article-title":"Host-directed therapy: a new arsenal to come","volume":"24","author":"Mohan","year":"2021","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.virol.2024.110239_bib98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2020.10.092","article-title":"Host-directed editing of the SARS-CoV-2 genome","volume":"538","author":"Mourier","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2024.110239_bib99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10989-022-10477-z","article-title":"Recent patents and FDA-approved drugs based on antiviral peptides and other peptide-related antivirals","volume":"29","author":"Mousavi Maleki","year":"2023","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.virol.2024.110239_bib100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imbio.2004.02.004","article-title":"The role of scavenger receptors in pathogen recognition and innate immunity","volume":"209","author":"Mukhopadhyay","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.virol.2024.110239_bib101","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1038\/ctg.2016.37","article-title":"Successful treatment of hepatitis C virus-associated oral lichen planus by interferon-free therapy with direct-acting antivirals","volume":"7","author":"Nagao","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.virol.2024.110239_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005947","article-title":"Life cycle synchronization is a viral drug resistance mechanism","volume":"14","author":"Neagu","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.virol.2024.110239_bib103","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/2.3.223","article-title":"Drug resistance and antiviral agents","volume":"2","author":"Oxford","year":"1976","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.virol.2024.110239_bib104","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.pu.09.050188.001223","article-title":"Viral vaccines and antivirals: current use and future prospects","volume":"9","author":"Parkman","year":"1988","journal-title":"Annu. Rev. Publ. Health"},{"key":"10.1016\/j.virol.2024.110239_bib105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/bmj.317.7159.660","article-title":"Antiviral drug resistance","volume":"317","author":"Pillay","year":"1998","journal-title":"Br. Med. J."},{"key":"10.1016\/j.virol.2024.110239_bib106","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/rmv.1787","article-title":"Antiviral drug resistance in herpesviruses other than cytomegalovirus","volume":"24","author":"Piret","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib107","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.virol.2024.110239_bib108","article-title":"Clinical considerations on monkeypox antiviral medications: an overview","volume":"12","author":"Pourkarim","year":"2024","journal-title":"Pharmacol. Res. pers."},{"key":"10.1016\/j.virol.2024.110239_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119551","article-title":"A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections","volume":"291","author":"Pradhan","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.virol.2024.110239_bib110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrmicro.2017.29","article-title":"A CRISPR toolbox to study virus-host interactions","volume":"15","author":"Puschnik","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2024.110239_bib111","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/AAC.01236-09","article-title":"Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors","volume":"54","author":"Puyang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2024.110239_bib112","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1128\/AAC.00561-10","article-title":"Characterization of dengue virus resistance to brequinar in cell culture","volume":"54","author":"Qing","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2024.110239_bib113","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/infdis\/134.1.30","article-title":"Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines. I. Description and characterization of adoptive transfer by immune spleen cells","volume":"134","author":"Rabinowitz","year":"1976","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110239_bib114","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.01863-12","article-title":"HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120","volume":"87","author":"Ratcliff","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-1702(01)00237-4","article-title":"Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus","volume":"75","author":"Ray","year":"2001","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2024.110239_bib116","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2024.110239_bib117","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.1840030612","article-title":"Immunoregulatory T cell subsets in chronic hepatitis B virus infection: the influence of homosexuality","volume":"3","author":"Regenstein","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2024.110239_bib118","first-page":"34","article-title":"[Cytokines and antiviral immuniy]","volume":"37","author":"Riazantseva","year":"2006","journal-title":"Usp. Fiziol. Nauk"},{"key":"10.1016\/j.virol.2024.110239_bib119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2006.03.004","article-title":"Antiviral drug resistance","volume":"71","author":"Richman","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110239_bib120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijid.2014.09.001","article-title":"Are we ready for a global pandemic of Ebola virus?","volume":"28","author":"Ross","year":"2014","journal-title":"Int. J. Infect. Dis. : Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110239_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2020.103847","article-title":"A TLR7 agonist activates bovine Th1 response and exerts antiviral activity against bovine leukemia virus","volume":"114","author":"Sajiki","year":"2021","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.virol.2024.110239_bib122","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/hep.1840050308","article-title":"Suppression of T helper function: an immunoregulatory effect of rosette inhibitory factor in hepatitis B virus infection","volume":"5","author":"Sanders","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2024.110239_bib123","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of immune response during SARS-CoV-2 infection: lessons from the past","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2024.110239_bib124","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1128\/JVI.00034-11","article-title":"An anti-inflammatory role of VEGFR2\/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology","volume":"85","author":"Sharma","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib125","doi-asserted-by":"crossref","first-page":"19001","DOI":"10.1073\/pnas.1107087108","article-title":"T cell immunoglobulin and mucin protein-3 (Tim-3)\/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses","volume":"108","author":"Sharma","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2024.110239_bib148","doi-asserted-by":"crossref","first-page":"001840","DOI":"10.1099\/jgv.0.001840","article-title":"Virus taxonomy and the role of the International Committee on Taxonomy of Viruses (ICTV)","volume":"104","author":"Siddell","year":"2023","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0065-3527(08)60862-3","article-title":"Interferon-induced proteins and the antiviral state","volume":"38","author":"Staeheli","year":"1990","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2024.110239_bib127","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00103-010-1166-0","article-title":"[The pandemic influenza virus H1N1\/2009: a review of the molecular biology, phylogeny, history of reassortments, and parameters of host switching]","volume":"53","author":"Stech","year":"2010","journal-title":"Bundesgesundheitsblatt - Gesundheitsforsch. - Gesundheitsschutz"},{"key":"10.1016\/j.virol.2024.110239_bib128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acscentsci.2c01243","article-title":"A selective SARS-CoV-2 host-directed antiviral targeting stress response to reactive oxygen species","volume":"9","author":"Tang","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.virol.2024.110239_bib129","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/infdis\/jit562","article-title":"In vivo emergence of a novel mutant L159F\/L320F in the NS5B polymerase confers low-level resistance to the HCV polymerase inhibitors mericitabine and sofosbuvir","volume":"209","author":"Tong","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110239_bib130","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/eji.1830241227","article-title":"T lymphocyte-mediated antiviral immune responses in mice are diminished by treatment with monoclonal antibody directed against the interleukin-2 receptor","volume":"24","author":"Utermohlen","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2024.110239_bib131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejphar.2017.05.038","article-title":"New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections","volume":"809","author":"van de Wakker","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.virol.2024.110239_bib132","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3390\/v7082832","article-title":"Replication and inhibitors of enteroviruses and parechoviruses","volume":"7","author":"van der Linden","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110239_bib133","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/cr.2012.129","article-title":"Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication","volume":"22","author":"van der Schaar","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.virol.2024.110239_bib134","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virol.2018.07.014","article-title":"Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin","volume":"522","author":"Vanwalscappel","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110239_bib135","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110239_bib136","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1373\/clinchem.2014.237016","article-title":"The sequence of the human genome","volume":"61","author":"Venter","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.virol.2024.110239_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29555","article-title":"Hesperetin blocks poxvirus replication with a low tendency to select for drug-resistant viral variants","volume":"96","author":"Verma","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib138","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1098\/rspb.2000.1079","article-title":"Adherence and drug resistance: predictions for therapy outcome","volume":"267","author":"Wahl","year":"2000","journal-title":"Proc. Biol. sci."},{"key":"10.1016\/j.virol.2024.110239_bib139","article-title":"Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2","volume":"8","author":"Wali","year":"2022","journal-title":"J. virus eradi."},{"key":"10.1016\/j.virol.2024.110239_bib140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41577-022-00734-z","article-title":"Host-directed immunotherapy of viral and bacterial infections: past, present and future","volume":"23","author":"Wallis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2024.110239_bib141","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1534\/genetics.105.045922","article-title":"Lysis timing and bacteriophage fitness","volume":"172","author":"Wang","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.virol.2024.110239_bib142","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.1128\/JVI.00385-12","article-title":"Biological roles and functional mechanisms of arenavirus Z protein in viral replication","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib143","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coviro.2012.08.008","article-title":"Clinical relevance of HCV antiviral drug resistance","volume":"2","author":"Welsch","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib144","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/gutjnl-2013-306155","article-title":"Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C","volume":"64","author":"Xiao","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.virol.2024.110239_bib145","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00791-17","article-title":"Enterovirus 3A facilitates viral replication by promoting phosphatidylinositol 4-kinase IIIbeta-ACBD3 interaction","volume":"91","author":"Xiao","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110239_bib146","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac047","article-title":"Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs","volume":"23","author":"Xie","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.virol.2024.110239_bib147","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.26097","article-title":"The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination","volume":"57","author":"Zahid","year":"2013","journal-title":"Hepatology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:33:27Z","timestamp":1764599607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224002605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":148,"alternative-id":["S0042682224002605"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110239","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of drug resistance against antiviral agents that target cellular factors","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110239"}}